CR11639A - Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico - Google Patents

Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico

Info

Publication number
CR11639A
CR11639A CR11639A CR11639A CR11639A CR 11639 A CR11639 A CR 11639A CR 11639 A CR11639 A CR 11639A CR 11639 A CR11639 A CR 11639A CR 11639 A CR11639 A CR 11639A
Authority
CR
Costa Rica
Prior art keywords
compound
diamine
tiazol
dihidro
etil
Prior art date
Application number
CR11639A
Other languages
English (en)
Inventor
C Iii Blackwell William
Hulsizer James
Wei Liu Jian
Steelman Gary
Urbanek Rebecca
Widzowski Dan
Wu Ye
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CR11639A publication Critical patent/CR11639A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Abstract

Esta invencion se refiere al compuesto de Formula 1 y sus sales farmaceuticamente aceptables: (R)-N*6*-etil-6,7-dihidro-5H-indenol[5,6-d]tiazol-2,6-diamina. Esta invencion tambien se refiere a metodos para sintetizar, metodos para utilizar y a composiciones farmaceuticas que comprenden el compuesto de Formula 1 y sus sales.
CR11639A 2008-02-21 2010-08-20 Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico CR11639A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3033208P 2008-02-21 2008-02-21

Publications (1)

Publication Number Publication Date
CR11639A true CR11639A (es) 2010-10-05

Family

ID=40985770

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11639A CR11639A (es) 2008-02-21 2010-08-20 Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico

Country Status (24)

Country Link
US (1) US20090215841A1 (es)
EP (1) EP2254876A4 (es)
JP (1) JP2011512407A (es)
KR (1) KR20100122487A (es)
CN (1) CN101952266A (es)
AR (1) AR070618A1 (es)
AU (1) AU2009215920A1 (es)
BR (1) BRPI0907158A2 (es)
CA (1) CA2716215A1 (es)
CL (1) CL2009000392A1 (es)
CO (1) CO6300849A2 (es)
CR (1) CR11639A (es)
DO (1) DOP2010000257A (es)
EA (1) EA201001095A1 (es)
EC (1) ECSP10010412A (es)
IL (1) IL206817A0 (es)
MX (1) MX2010008923A (es)
NI (1) NI201000141A (es)
PE (1) PE20091566A1 (es)
SA (1) SA109300120B1 (es)
TW (1) TW200940516A (es)
UY (1) UY31668A1 (es)
WO (1) WO2009105026A1 (es)
ZA (1) ZA201004800B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017219808A1 (zh) * 2016-06-21 2017-12-28 浙江柏拉阿图医药科技有限公司 丙型肝炎病毒抑制剂及应用
CN109134600B (zh) * 2017-06-19 2021-07-20 杭州国谋生物科技有限公司 作为丙型肝炎抑制剂的烷基及杂环化合物及其在药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802360D0 (sv) * 1998-07-01 1998-07-01 Wikstroem Hakan Vilhelm New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin
WO2005084205A2 (en) * 2004-02-27 2005-09-15 Teva Pharmaceutical Industries, Ltd. Diamino thiazoloindan derivatives and their use

Also Published As

Publication number Publication date
SA109300120B1 (ar) 2011-10-08
DOP2010000257A (es) 2010-10-31
UY31668A1 (es) 2009-09-30
EP2254876A1 (en) 2010-12-01
KR20100122487A (ko) 2010-11-22
CN101952266A (zh) 2011-01-19
TW200940516A (en) 2009-10-01
PE20091566A1 (es) 2009-11-06
NI201000141A (es) 2011-03-24
MX2010008923A (es) 2010-09-07
JP2011512407A (ja) 2011-04-21
US20090215841A1 (en) 2009-08-27
CL2009000392A1 (es) 2010-09-24
ZA201004800B (en) 2012-06-27
BRPI0907158A2 (pt) 2015-07-07
AU2009215920A1 (en) 2009-08-27
CA2716215A1 (en) 2009-08-27
EP2254876A4 (en) 2012-10-31
CO6300849A2 (es) 2011-07-21
ECSP10010412A (es) 2010-09-30
AR070618A1 (es) 2010-04-21
EA201001095A1 (ru) 2011-04-29
WO2009105026A1 (en) 2009-08-27
IL206817A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
GT200800242A (es) Derivados biciclicos como inhibidores de cetp
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
GT200600117A (es) Nuevos compuestos farmaceuticos
CR20140392A (es) Dihidropirazolonas sustituidas
UY30824A1 (es) Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones.
SV2008003045A (es) Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes
AR052404A1 (es) Hidratos y polimorfos de 4-(((7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil)amino)-3- metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparacion y su uso como farmaco
CR10662A (es) Compuestos de metilpiridopirimidinona
CO6321276A2 (es) Derivados de tiazol usados como inhibidores de pi3- cinasa
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
UY33337A (es) DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
UY30748A1 (es) Compuesto0s novedosos
CR10356A (es) Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3
CR11452A (es) 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios
UY31457A1 (es) Derivados acidos de cicloalquilamino
DOP2006000017A (es) Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
ECSP099565A (es) Compuesto de 2-amino pirimidina
CR10557A (es) Bencilaminas, un proceso para la produccion y su uso como agentes antiinflamatorios
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
UY32713A (es) Nuevos agentes antihelmínticos heterocíclicos y su uso.
BR112012009311A2 (pt) composto, composição farmacêutica, e, uso do composto
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
ECSP10010200A (es) Derivados de pirazol como inhibidores de 5-lo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)